Ginsenoside Rh2 inhibits breast cancer cell growth viaERβ-TNFα pathway: Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα

por Peng, Kunjian, Luo, Tiao, Li, Jijia, Huang, Jingjia, Dong, Zizeng, Liu, Jia, Pi, Chaoqiong, Zou, Zizeng, Gu, Qin, Liu, Ousheng, Zhang, Jian-Ting, Luo, Zhi-Yong
Publicado 2022

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation

por Xie, Yuanzhu, Zhu, Shuaiwen, Chen, Ling, Liu, Hongdou, Peng, Ting, Ming, Zhengnan, Zou, Zizheng, Hu, Xiyuan, Luo, Wensong, Peng, Kunjian, Nie, Yuan, Luo, Tiao, Ma, Dayou, Liu, Suyou, Luo, Zhiyong
Publicado 2023

ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling

por Su, Min, Huang, Jingjia, Li, Jijia, Qin, Xiyuan, Tang, Xiaoning, Jin, Fang, Chen, Shali, Jiang, Chuanming, Zou, Zizheng, Peng, Kunjian, Nuruzzaman, Mohammed, Zhang, Jianting, Luo, Junli, Liu, Suyou, Luo, Zhiyong
Publicado 2016

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor

por Zou, Zizheng, Hu, Xiyuan, Luo, Tiao, Ming, Zhengnan, Chen, Xiaodan, Xia, Li, Luo, Wensong, Li, Jijia, Xu, Na, Chen, Ling, Cao, Dongsheng, Wen, Min, Kong, Fanrong, Peng, Kunjian, Xie, Yuanzhu, Li, Xuan, Ma, Dayou, Yang, Chuanyu, Chen, Ceshi, Yi, Wenjun, Liu, Ousheng, Liu, Suyou, Luo, Junli, Luo, Zhiyong
Publicado 2021